Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents.

Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents. Abstract Text:

    a barnettA Barnett,a barnettA Barnett,

    A recently published American Diabetes Association/European Association for the Study of Diabetes consensus statement on the management of hyperglycaemia in type 2 diabetes emphasises the achievement and maintenance of normal glycaemic control and the rapid addition of medications and transition to new regimens when glycaemic goals are not achieved or sustained. An algorithm for the use of available interventions is supplied to help practitioners avoid prolonged periods of inadequate glycaemic control. Recommendations include rapid transition to combination treatment with oral agents and with insulin plus oral agents. The currently available oral agents are reviewed here with respect to the consensus statement recommendations, and the characteristics of the new class of oral dipeptidyl peptidase-4 inhibitors are summarised. These agents offer clinically meaningful reductions in HbA1c without significant risk of hypoglycaemia and without causing weight gain; they also offer the theoretical potential of improving or maintaining beta-cell function and thus, favourably affecting the progressive loss of function that is characteristic of type 2 diabetes. Potential uses of these agents in the context of the consensus statement recommendations are considered.

    Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents. Publishing Authors By Initials

    a barnettA Barnett,a barnettA Barnett,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents. Journal Published:

    PUBLICATION TYPE: Review

    Journal: International journal of clinical practice. Supple

    VOLUME:

    Page Numbers: 12-8

    Journal Abbreviation:

    ISSN: 1368-504X

    DAY: 26

    MONTH: Aug

    YEAR: 2007

    Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents. Information

    Number of References: 51

    LANGUAGE: eng

    NlmUniqueID: 9712380

    Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents.

    AFFILIATION: University of Birmingham and Heart of England National Health Service Foundation Trust (Teaching), Birmingham, UK. anthony.barnett@heartofengland.nhs.uk

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Int J Clin Pract Suppl

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News